Interventional cardiology during the COVID-19 epidemic

Simple item page
dc.contributor.authorWeich, Hellmuthen_ZA
dc.contributor.authorHitzeroth, Jensen_ZA
dc.contributor.authorKhan, Sajidahen_ZA
dc.contributor.authorKettles, Daviden_ZA
dc.contributor.authorVachiat, Ahmeden_ZA
dc.contributor.authorNtsekhe, Mpikoen_ZA
dc.date.accessioned2021-02-23T09:14:03Z
dc.date.available2021-02-23T09:14:03Z
dc.date.issued2020
dc.descriptionCITATION: Weich, H., et al. 2020. Interventional cardiology during the COVID-19 epidemic. SA Heart, 17(3):296-304, doi:10.24170/17-3-4376.
dc.descriptionThe original publication is available at http://www.journals.ac.za/index.php/SAHJ
dc.description.abstractENGLISH ABSTRACT: The impact of the COVID-19 pandemic on our lives is unprecedented and major adjustments to our practices as physicians are required. Although our comments are applicable at the time of writing, the situation changes daily and the content of this article should be adjusted accordingly. Cath lab: An unambiguous cath lab protocol should be drawn up for each facility, appropriate to local circumstances. This should include standard procedures in preparation for arrival at the lab, in the performance of procedures, and, importantly, in maintaining due diligence when removing protective gear. All team members should be well trained in these procedures. Acute coronary syndromes: Standard timing for the invasive management of patients should not change during the pandemic. Due to delays often unavoidable during the pandemic, alternative strategies such as thrombolysis may be more readily available and therefore more appropriate. Drugs: The sick COVID-19 patient often represents a pro-thrombotic state and operators should ensure adequate anti-thrombotic therapy. Knowledge of interactions between cardiac drugs and investigational antiviral treatments is important. Elective procedures: Patients with chronic cardiac conditions are at high risk and may require non-urgent procedures to avert major complications. Selecting these cases requires consideration of multiple risks and benefits.en_ZA
dc.description.urihttps://www.journals.ac.za/index.php/SAHJ/article/view/4376
dc.description.versionPublisher's version
dc.format.extent9 pagesen_ZA
dc.identifier.citationWeich, H., et al. 2020. Interventional cardiology during the COVID-19 epidemic. SA Heart, 17(3):296-304, doi:10.24170/17-3-4376
dc.identifier.issn2071-4602 (online)
dc.identifier.issn1996-6741 (print)
dc.identifier.otherdoi:10.24170/17-3-4376
dc.identifier.urihttp://hdl.handle.net/10019.1/109586
dc.language.isoen_ZAen_ZA
dc.publisherSouth African Heart Associationen_ZA
dc.rights.holderAuthors retain copyrighten_ZA
dc.subjectCOVID-19en_ZA
dc.subjectCOVID-19 Pandemic, 2020-en_ZA
dc.subjectCoronary heart diseaseen_ZA
dc.subjectThrombolytic therapyen_ZA
dc.subjectCardiac drugsen_ZA
dc.titleInterventional cardiology during the COVID-19 epidemicen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
weich_interventional_2020.pdf
Size:
92.06 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Cardiology)